Products

Products

Hepatitis B Antibody
  • Hepatitis B AntibodyHepatitis B Antibody

Hepatitis B Antibody

AIM Honesty Biopharmaceutical Co., Ltd. is a professional manufacturer and supplier of hepatitis B vaccines. Our independently developed RECVAX® recombinant hepatitis B vaccine (Pichia pastoris) utilizes a domestically pioneered and internationally leading recombinant Pichia pastoris expression technology platform and patented adjuvant technology, providing long-lasting protection by inducing the formation of Hepatitis B antibody in vaccinated individuals.

After successful hepatitis B vaccination, Hepatitis B Antibody formed. So, if you're looking for a reliable vaccine, consider AIM Honesty Biopharmaceutical Co., Ltd. from China as your supplier. Our RECVAX® series of hepatitis B vaccines are manufactured according to stricter pharmacopoeia standards, resulting in enhanced safety and protective efficacy.

Hepatitis B Antibody

Why Is Hepatitis B Vaccination Necessary?

Hepatitis B, a viral liver disease, can develop into chronic liver disease, increasing the risk of cirrhosis and liver cancer. It is a disease that urgently needs prevention, which itself highlights the necessity of vaccination.

According to recommendations from the U.S. Centers for Disease Control and Prevention (CDC), vaccination provides highly effective protection with minimal side effects, which may include mild fever and pain at the injection site. It is a safe and effective way to protect against the disease.

Vaccination Precautions

1. Although AIM Honesty's vaccine is suitable for most age groups, caution should be exercised in the following cases: individuals with a family or personal history of convulsions, a history of chronic diseases, a history of epilepsy, and those with allergic constitutions.

2. The vaccine should be shaken well before use. If undissolved clots or foreign objects are found in the vaccine, or if the vaccine vial is broken or the label is unclear, it should not be used for safety reasons.

3. Use immediately after opening.

4. Adrenaline and other medications should be available for emergency use in case of a severe allergic reaction. Vaccine recipients should be observed on-site for at least 30 minutes after vaccination.

5. If abnormal conditions such as high fever or convulsions occur after the first vaccination, a second vaccination should generally not be given; for infants receiving mother-to-child transmission prevention, the second and third vaccinations should be given according to medical advice.

6. Store and transport at 2-8℃ away from light, but freezing is strictly prohibited.

Product Features and Applications

RECVAX® series vaccines utilize advanced technology. Upon administration, they effectively create an antigen reservoir within the body, allowing for sustained antigen release, longer-lasting effects, and a better immune response. Over the past 20 years since its launch, our vaccine has covered 31 provinces, municipalities, and autonomous regions in China. We welcome collaborations with purchasers nationwide to provide immunization solutions to more people.

Regarding efficacy, a study led by Academician Li Lanjuan evaluated the booster immunization effects of four different hepatitis B vaccines in children aged 5 to 15 years.

After receiving a booster dose of 10 μg RECVAX® (Hansenula polymorpha) vaccine using the 0-1-6 month schedule, the anti-HBs seropositivity rates at 1, 5, and 8 years post-booster immunization all reached 83.4%, the highest among all four vaccines.

Hot Tags: Hepatitis B Antibody, China, Manufacturer, Supplier, Factory
Send Inquiry
Contact Info
  • Address

    ● 26F, T6, Dazu Square, NO.2 Ronghua South Road, ETDZ, Beijing, China
    ● 10F, Port Building, 1 Fenghe Road, Pudong, Shanghai, China

For inquiries about human rabies vaccine, hepatitis B vaccine, hepatitis A vaccine or price list, please leave your email to us and we will be in touch within 24 hours.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept